Tech Startups and SMEs Share €90m of EU Funds to Disrupt the European Markets

European CommissionThe European Commission is committing €90 million to Open and Disruptive Innovation over the next 12 months. A new tool to help doctors communicate with non-responsive patients; a cloud-based irrigation controller to improve water efficiency on farms by up to 30%; an "electronic nose" to better determine how fresh your food is - these are a few of the 30 tech SMEs and start-ups to receive EU funding. Find out who the tech winners are and what their idea is about.

SMEs from Austria, Denmark, Finland, France, Ireland, Israel, Lithuania, Poland, Slovenia, Spain, Turkey and the UK were selected to receive €50 thousand each (€1.5million overall EU funding) over 6 months at most, to render their business idea technically and commercially viable.

European Commission Vice-President Neelie Kroes said: "I always believed SMEs generate the kind of innovative ideas that bring growth and jobs, the ideas Europe needs today. This new instrument was created to precisely unleash this potential, to allow individual SMEs access funding that can allow them make their brilliant idea a reality. I want to congratulate the first set of winners and invite more of Europe's brilliant innovators to come ahead. The future belongs to you!"

Most of the 30 SMEs selected are 2 to 5 years old. Chosen from 886 proposals, they are innovative businesses and new high tech spin-offs from R&D bodies with a strong commercial dimension.

On September 24, on October 9 and on December 17 more winning SMEs will be announced; on these three occasions, funding of up to €43m will be offered to support SMEs from concept creation till commercialisation.

More about Open and Disruptive Innovation (ODI)
ODI is an ICT-dedicated funding scheme under Horizon 2020 that aims to transform disruptive ideas into concrete, innovative solutions (products, services, models) and create new markets with a European and global impact. Find out more on the ODI scheme here.

The SME instrument is a novel approach to supporting SMEs' innovation activities, covering the whole innovation cycle. It is conceived to offer access to EU funds to more SMEs, to provide support to a wider range of innovation activities and to help increase the economic impact of project results by its company-focused and market-driven approach.

Applications to the SMEs instrument are open all year long. These applications are evaluated at regular intervals called "cut-off days". Find upcoming cut-off dates here.

For further information on SME Instrument structure and support offered, pleae visit:
http://ec.europa.eu/programmes/horizon2020/en/h2020-section/sme-instrument

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...